Nasal spray could tame racing heart in AFib patients
Symptom relief
Not yet recruiting
This study tests an experimental nasal spray called etripamil for people with atrial fibrillation (AFib) who experience episodes of dangerously fast heart rate. Participants will use the spray at home when symptoms start, with an optional second dose if needed. The goal is to see…
Phase: PHASE3 • Sponsor: Milestone Pharmaceuticals Inc. • Aim: Symptom relief
Last updated May 22, 2026 14:03 UTC